KELLIE BINEGAR: Open Payments
NPI 1356724751 · WASHINGTON COURT HOUSE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 24 payments from 20 companies in 2025. Trend: 2023 $626 · 2024 $457 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Astellas Pharma US Inc | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Viatris Specialty LLC | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: CAPLYTA, Veozah, REXULTI, Qelbree, YUPELRI, Auvelity, UBRELVY, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
